肝细胞癌
医学
肝硬化
内科学
胃肠病学
流行病学
阶段(地层学)
风险因素
癌
古生物学
生物
作者
Yi Dong,Wen‐Ping Wang,Won Jae Lee,Maria Franca Meloni,Dirk‐André Clevert,Maria Cristina Chammas,Andrea Tannapfel,A. Forgione,Fabio Piscaglia,Christoph F. Dietrich
出处
期刊:Clinical Hemorheology and Microcirculation
[IOS Press]
日期:2021-11-26
卷期号:80 (4): 423-436
被引量:24
摘要
Liver cirrhosis is an established high-risk factor for HCC and the majority of patients diagnosed with HCC have cirrhosis. However, HCC also arises in non-cirrhotic livers in approximately 20 %of all cases. HCC in non-cirrhotic patients is often clinically silent and surveillance is usually not recommended. HCC is often diagnosed at an advanced stage in these patients. Current information about HCC in patients with non-cirrhotic liver is limited. Here we review the current knowledge on epidemiology, clinical features and imaging features of those patiens.
科研通智能强力驱动
Strongly Powered by AbleSci AI